Felipe C Geyer Selected Research

Fibrocystic Breast Disease (Chronic Cystic Mastitis)

1/2017	Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
4/2016	Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felipe C Geyer Research Topics

Disease

40	Neoplasms (Cancer) 01/2021 - 04/2009
26	Breast Neoplasms (Breast Cancer) 03/2022 - 04/2009
10	Carcinoma (Carcinomatosis) 01/2020 - 04/2009
4	Melanoma (Melanoma, Malignant) 12/2019 - 07/2010
4	Ductal Carcinoma 01/2012 - 11/2009
3	Neoplasm Metastasis (Metastasis) 08/2017 - 02/2011
3	Lobular Carcinoma 02/2017 - 02/2011
2	Pathologic Complete Response 03/2022 - 01/2018
2	Papillary Carcinoma 01/2020 - 08/2018
2	Triple Negative Breast Neoplasms 10/2017 - 01/2016
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Ovarian Epithelial Carcinoma 03/2011 - 04/2009
1	Intraductal Papilloma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 08/2018
1	Papillary Thyroid Cancer 08/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2018
1	Adenomyoepithelioma 01/2018
1	Endometrioid Carcinoma 09/2017
1	Metaplasia 01/2017
1	Acinar Cell Carcinoma 01/2017
1	Disease Progression 01/2016
1	Confusion (Bewilderment) 07/2013
1	Genetic Translocation (Chromosomal Translocation) 01/2012
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2010
1	Fibroma (Fibromatosis) 11/2010
1	Endometrial Neoplasms (Endometrial Cancer) 10/2010
1	Adenocarcinoma 10/2010
1	Adenosquamous Carcinoma 07/2010

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2019 - 04/2009
9	Phenobarbital (Luminal)FDA Link 01/2018 - 04/2009
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2010
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2010
5	Cadherins (E-Cadherin)IBA 01/2021 - 11/2010
5	Biological ProductsIBA 06/2018 - 06/2010
4	AntibodiesIBA 01/2020 - 11/2010
3	Monoclonal AntibodiesIBA 01/2020 - 12/2010
3	Pharmaceutical PreparationsIBA 12/2019 - 03/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2016 - 11/2010
3	CateninsIBA 07/2013 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 02/2011 - 10/2009
3	AnthracyclinesIBA 01/2011 - 10/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019 - 01/2019
2	Lapatinib (GW572016)FDA Link 01/2018 - 09/2017
2	Codon (Codons)IBA 01/2018 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 01/2018
2	Formaldehyde (Formol)FDA Link 03/2017 - 01/2012
2	ParaffinIBA 03/2017 - 01/2012
2	Keratin-14 (Keratin 14)IBA 10/2013 - 02/2012
2	CortactinIBA 12/2010 - 11/2010
2	Messenger RNA (mRNA)IBA 06/2010 - 04/2009
2	OligonucleotidesIBA 01/2010 - 11/2009
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 12/2019
1	MucinsIBA 01/2019
1	bis(pyridinio)dichlorocuprate(II)IBA 08/2018
1	neratinibIBA 09/2017
1	AfatinibIBA 09/2017
1	MTOR InhibitorsIBA 07/2017
1	Complex MixturesIBA 03/2017
1	Chromogranin AIBA 02/2017
1	SynaptophysinIBA 02/2017
1	Transcription Factors (Transcription Factor)IBA 02/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	ClaudinsIBA 01/2017
1	Cyclin-Dependent Kinase 2IBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	ChromograninsIBA 02/2012
1	AntigensIBA 02/2012
1	NucleotidesIBA 02/2012
1	Progesterone FDA LinkGeneric 02/2012
1	Androgen Receptors (Androgen Receptor)IBA 02/2012
1	Nonsense Codon (Nonsense Mutation)IBA 02/2012
1	Mucin-1 (CA 15-3 Antigen)IBA 02/2012
1	Keratin-7 (Cytokeratin 7)IBA 02/2012
1	Pyridinolcarbamate (P23)IBA 01/2012
1	Caveolin 1IBA 01/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2012
1	CarcinogensIBA 05/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	Cyclin D1IBA 11/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2010
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 10/2010
1	KU0058948IBA 10/2010
1	TensinsIBA 10/2010
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2010
1	MagnesiumIBA 10/2010
1	Indicators and Reagents (Reagents)IBA 08/2010
1	Cre recombinaseIBA 07/2010
1	Keratins (Keratin)IBA 07/2010

Therapy/Procedure

9	Therapeutics 01/2020 - 10/2009
8	Drug Therapy (Chemotherapy) 01/2020 - 10/2010
2	Neoadjuvant Therapy 03/2022 - 01/2020
2	Precision Medicine 12/2019 - 10/2017
1	Radiotherapy 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Lasers (Laser) 07/2019